{
    "clinical_study": {
        "@rank": "126163", 
        "brief_summary": {
            "textblock": "Our aim was to evaluate the effectiveness of subcutaneous allergen immunotherapy with the\n      symptom scores (RSS), visual analog scale (VAS) and medication scores (MS) and the impact\n      on quality of life with rhinoconjunctivitis quality of life questionnaire (RQLQ) in allergic\n      rhinitis patients sensitized to different allergens. Also the development of new\n      sensitizations and  asthma during the immunotherapy were determined."
        }, 
        "brief_title": "Allergen Immunotherapy in Allergic Patients", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Allergic Rhinitis", 
        "condition_browse": {
            "mesh_term": "Rhinitis"
        }, 
        "detailed_description": {
            "textblock": "Allergic rhinitis patients sensitized to at least one common aero-allergen who completed a\n      three or five year period of allergen immunotherapy in our outpatient clinic between\n      2002-2013 were enrolled in the study and patients with allergic rhinitis who received only\n      medical treatment were chosen as the control group.  Patients were separated in two groups\n      according to sensitization patterns including pollens or house dust mites. All patients were\n      evaluated before immunotherapy, in the first and the fifth years of treatment and  two years\n      after the treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  allergic rhinitis/asthma\n\n        Exclusion Criteria:\n\n          -  pregnancy,\n\n          -  malignity,\n\n          -  autoimmunity"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Allergic rhinitis patients sensitized to at least one common aero-allergen who completed a\n        three or five year period of allergen immunotherapy in our outpatient clinic between\n        2002-2013 were enrolled in the study and patients with allergic rhinitis who received only\n        medical treatment were chosen as the control group.  Patients were separated in two groups\n        according to sensitization patterns including pollens or house dust mites. All patients\n        were evaluated before immunotherapy, in the first and the fifth years of treatment and\n        two years after the treatment."
            }
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02040974", 
            "org_study_id": "1978"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "immunotherapy, house dust mites, pollens, allergic rhinitis", 
        "lastchanged_date": "January 17, 2014", 
        "location": {
            "contact": {
                "email": "mustafadt@yahoo.com", 
                "last_name": "Mustafa Demirturk"
            }, 
            "facility": {
                "address": {
                    "city": "Istanbul", 
                    "country": "Turkey", 
                    "zip": "34093"
                }, 
                "name": "Istanbul Faculty of Medicine"
            }, 
            "investigator": {
                "last_name": "Mustafa Demirturk", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "1", 
        "official_title": "Long Term Follow up in Patients Using Immunotherapy: Efficacy and Impact on Quality of Life", 
        "overall_official": {
            "affiliation": "Istanbul Faculty of Medicine", 
            "last_name": "Mustafa Demirturk", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The improvent of quality of life", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02040974"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Istanbul University", 
            "investigator_full_name": "Mustafa Demirturk", 
            "investigator_title": "expert in allergy and immunology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Istanbul University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Istanbul University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2007", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "7 Years", 
        "verification_date": "January 2014"
    }
}